Gates Foundation official discusses efforts to fight malaria

AllAfrica features an interview with David Brandling-Bennett, deputy director of the malaria program at the Bill & Melinda Gates Foundation, in which he discusses "current tools being used to fight the disease, the prospect for a vaccine, and the hope of new drugs to accelerate progress," according to the news service. "[R]ecent gains can be lost if we don't keep up the momentum" in the effort to eradicate malaria, Brandling-Bennett said, adding, "The longer it takes, the more we will have to deal with issues of the parasite's resistance and the ability of the human population to sustain a long-term effort," AllAfrica reports. He discusses the success of Path's Malaria Control and Evaluation Partnership in Africa (Macepa) program in Zambia and efforts to tackle malaria in Nigeria, according to the interview transcript. "There is a lot of work to be done to extend the gains we have got but also to build upon those so that we actually do achieve interruption of transmission in more and more places and eventually eradication. Working toward eradication is the only viable long-term strategy to fight malaria," Brandling-Bennett said, the transcript reports (1/10).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Deforestation drives a surge in malaria cases in the Amazon